Notify me when Laxminarayan Bhat files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS, INC. | Common Stock, par value $0.0001 per share | 3.8% | $1,877,246 | $34,929 | 3,680,874 | +1.9% | Bhat Laxminarayan | 22 Sep 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|